» Articles » PMID: 19429845

Fibroblast Growth Factors in Schizophrenia

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2009 May 12
PMID 19429845
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

A large association study by O'Donovan et al recently suggested that genetic variation in fibroblast growth factor receptor (FGFR) 2 increases the risk for developing schizophrenia. Fibroblast growth factors (FGFs) are part of the family of glial growth factors; they control the growth and patterning of specific brain structures and regulate the maintenance and repair of neuronal tissues. In addition, a direct interaction was recently found between FGFRs and adenosine A(2A) receptors, leading to corticostriatal plasticity and antagonizing the signaling pathway of dopamine D(2) receptors. These findings make FGFs plausible candidate genes for schizophrenia. Here, we review the role of FGFs in schizophrenia and combine evidence from studies on variations in FGF genes, RNA expression, protein levels, and FGF administration, as well as the effects of medication and environmental risk factors for schizophrenia. These data suggest that changes in the FGF system contribute to schizophrenia and possibly to a wider range of psychiatric disorders. The role of FGFs in schizophrenia and related disorders needs to be studied in more detail.

Citing Articles

Transcriptome analysis to explore the mechanism of downregulated TNIK influencing the effect of risperidone.

Yuan R, Li Y, Li X, Fu Y, Ning A, Wang D Front Pharmacol. 2024; 15:1431923.

PMID: 39268461 PMC: 11391209. DOI: 10.3389/fphar.2024.1431923.


Single-cell genomics and regulatory networks for 388 human brains.

Emani P, Liu J, Clarke D, Jensen M, Warrell J, Gupta C Science. 2024; 384(6698):eadi5199.

PMID: 38781369 PMC: 11365579. DOI: 10.1126/science.adi5199.


Single-cell genomics and regulatory networks for 388 human brains.

Emani P, Liu J, Clarke D, Jensen M, Warrell J, Gupta C bioRxiv. 2024; .

PMID: 38562822 PMC: 10983939. DOI: 10.1101/2024.03.18.585576.


DeepGAMI: deep biologically guided auxiliary learning for multimodal integration and imputation to improve genotype-phenotype prediction.

Chandrashekar P, Alatkar S, Wang J, Hoffman G, He C, Jin T Genome Med. 2023; 15(1):88.

PMID: 37904203 PMC: 10617196. DOI: 10.1186/s13073-023-01248-6.


Maternal FGF2 levels associated with child anxiety and depression symptoms through child FGF2 levels.

Lebowitz E, Marin C, Orbach M, Salmaso N, Vaccarino F, Silverman W J Affect Disord. 2023; 326:193-197.

PMID: 36717031 PMC: 10104478. DOI: 10.1016/j.jad.2023.01.090.


References
1.
Williams E, Walsh F, Doherty P . The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response. J Cell Biol. 2003; 160(4):481-6. PMC: 2173733. DOI: 10.1083/jcb.200210164. View

2.
Raffioni S, Thomas D, Foehr E, Thompson L, Bradshaw R . Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells. Proc Natl Acad Sci U S A. 1999; 96(13):7178-83. PMC: 22045. DOI: 10.1073/pnas.96.13.7178. View

3.
Vaccarino F, Schwartz M, Raballo R, Nilsen J, Rhee J, Zhou M . Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci. 1999; 2(3):246-53. DOI: 10.1038/6350. View

4.
Moises H, Zoega T, Gottesman I . The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry. 2002; 2:8. PMC: 117774. DOI: 10.1186/1471-244x-2-8. View

5.
Kamnasaran D, Muir W, Ferguson-Smith M, Cox D . Disruption of the neuronal PAS3 gene in a family affected with schizophrenia. J Med Genet. 2003; 40(5):325-32. PMC: 1735455. DOI: 10.1136/jmg.40.5.325. View